Form 4: Apyx Medical Corp CFO Matthew C. Hill Acquires Shares

Matthew C. Hill, CFO of Apyx Medical Corp, purchased 5,336 shares of common stock at an average price of $1.13 on August 13, 2024.

Summary

• On August 13, 2024, Matthew C. Hill, the Chief Financial Officer of Apyx Medical Corp, acquired 5,336 shares of the company's common stock.
• The purchase was made at a weighted average price of $1.13 per share, with individual trades ranging from $1.12 to $1.13.
• Following the transaction, Hill directly owns 7,836 shares of Apyx Medical Corp.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CFO's purchase of shares is a positive signal, but the magnitude is not significant enough to warrant a strong positive sentiment.

Positives

• The CFO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. A purchase by a key executive like the CFO is often seen as a positive sign.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates